期刊文献+

Galectin-9对活化的CD4^+T细胞免疫调节作用的机制研究 被引量:3

The mechanism of Galectin-9 in the immune regulation of the active CD4+ T cells
原文传递
导出
摘要 目的研究Galectin-9对活化的CD4+T细胞的免疫调节作用,并进一步探讨其作用机制。方法获取野生型C57BL/6小鼠淋巴细胞,利用MACS分选CIM+naiveT细胞,给予anti-CD3(2.5μm1)抗体、anti-CD28(5μg/ml)抗体和IL-2(100ng/ml)刺激,培养3d。将活化的CD4+T细胞分为3组:正常对照组、Galectin-9组和Galectin-9+α-乳糖组。利用CFSE检测T细胞增殖情况,并动态观察细胞形态变化;检测CD4+CD69+T细胞、Thl、Th2和Thl7细胞的比例;并利用ELISA检测淋巴细胞分泌IFN-γ、IL-4、IL-10、IL-12、IL-17A和TGF-β1等细胞因子的水平;利用Westernblot检测T-bet、GATA-3和ROR-γt等T细胞分化调控蛋白的变化。结果与正常对照组和Galectin-9+α-乳糖组相比,Galectin-9组于2h时开始出现细胞形态改变,同时CD4+CD69+T细胞、Thl和Thl7细胞表达减少(P〈0.05),但Th2细胞无明显变化;培养上清液中IFN-γ、IL-12、IL-17A和TGF-β1的表达水平降低(P〈0.05),而IL-4和IL-10等Th2型细胞因子水平无明显变化;同时T-bet和ROR-γt的表达水平减少(P〈0.05)。结论Galectin-9抑制活化CD4+T细胞的Thl和Thl7型免疫应答,而对Th2型免疫应答无影响,免疫调节的机制可能与其在转录水平影响Thl和Thl7特定转录因子的表达有关。 Objective To study the immune regulation of Galectin-9 on the active CIM+T cells and demonstrate the mechanisms. Methods Lymphocytes were harvested from Mid-type C57BL/6 mouse, from which nayve CD4+T cells were separated via MACS and then stimulated with anti-CD3 antibody(Ab) (2.5μg/ml), anti-CD28 Ab(5 μg/ml) and IL-2( 100 ng/ml) for 3 days. The active CIM+T cells were di- vided into 3 groups: Control group, Galectin-9 group and Galectin-9+α-lactose group. We detected the cell proliferation level by CFSE fluorescence intensity and then dynamically observed the cell morphological chan- ges. The proportion of CIM+CD69+T cell, Thl, Th2 and Thl7 cell was valued; Meanwhile, ELISA was used to detect the cytokine levels of IFN-γ, IL-4, IL-10, IL-12, IL-17A and TGF-β1 secreted by lympho- cytes. Also Western blot was used to observe the changes of T cell differentiation regulatory protein such as T-bet, GATA-3 and ROR-γt. Results Compared with control group and Galectin-9+c^-lactose group, in Galectin-9 group, the cell morphology began to change at 2 h. Moreover the proportions of CIM+CD69+ T cell, Thl and Thl7 cells decreased(P〈0.05), but no significant differences in Th2 cells. The level of IFN-γ, IL-12, IL-17A and TGF-β1 from the supernatant decreased (P〈0.05), while Th2-type cytokines IL-4 and IL-10 did not change. In addition, the expressions of T-bet and ROR-γt were significantly down-regula- ted(P〈0.05). Conclusion Galectin-9 inhibited Thl and ThlT-type immune response, while had no effect on Th2-type immune response. The mechanism of the immune regulation may be related to affect the expres- sion of Thl and Thl7 specific transcription factors at transcription level.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2012年第9期792-797,共6页 Chinese Journal of Microbiology and Immunology
基金 湖北省自然科学基金(2009CDB373) 博士点新教师基金(200804871041) 国家自然科学基金(30800524)
关键词 GALECTIN-9 TH2 TH2 TH17 -Galectin-9 TIll Th2 Th17
  • 相关文献

参考文献17

  • 1Wada J, Kanwar YS. Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. J Biol Chem, 1997, 272(9) : 6078-6086.
  • 2Monney L, Sabatos CA, Gaglia JL, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature, 2002, 415(6871): 536-541.
  • 3Anderson AC, Anderson DE, Bregoli L, et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science, 2007, 318 (5853) : 1141-1143.
  • 4Niwa H, Satoh T, Matsushima Y, et al. Stable form of galectin-9,a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and/or Th17-mediated skin inflammation. Clin Immunol, 2009, 132(2) : 184-194.
  • 5Zhu C, Anderson AC, Schubart A, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol, 2005, 6(12) : 1245-1252.
  • 6Wilker PR, Sedy JR, Grigura V, et al. Evidence for carbohydrate recognition and homotypie and heterotypie binding by the TIM family. Int Immunol, 2007, 19(6) : 763-773.
  • 7Oikawa T, Kamimura Y, Akiba H, et al. Preferential involvement of Tim-3 in the regulation of hepatic CD8^+ T cells in murine acute graft-versus-host disease. J Immunol, 2006, 177 ( 7 ) : 4281- 4287.
  • 8Pan HF, Zhang N, Li WX, et al. TIM-3 as a new therapeutic target in systemic lupus erythematosus. Mol Biol Rep, 2010, 37 ( 1 ) : 395-398.
  • 9Koguchi K, Anderson DE, Yang L, et al. Dysregulated T cell expression of TIM3 in multiple sclerosis. J Exp Med, 2006, 203(6) : 1413-1418.
  • 10Sanchez-Fueyo A, Tian J, Picarella D, et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol, 2003, 4 ( 11 ) : 1093-1101.

同被引文献32

  • 1耿呈云,薛新波.TGF-β1、Smad7在甲状腺癌中的表达和意义[J].临床外科杂志,2006,14(3):145-146. 被引量:6
  • 2ANDERSON A C. Tim-3,a negative regulator of anti-tumorimmunity [ J ] . Curr Opin Immunol,2012,24 ( 2 ) : 213-216.
  • 3CHABTINI L,MFARREJ B,MOUNAYAR M,et al. TIM-3regulates innate immune cells to induce fetomaternal toler-ance [J]. J Immunol,2013,190( 1) :88-96.
  • 4ZHU C,ANDERSON A C,SCHUBART A,et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1immunity [ J ]. Nat Immunol, 2005 ,6(12) : 1245-1252.
  • 5LV K,ZHANG Y,ZHANG M,et al. Galectin-9 amelio-rates Con A-induced hepatitis by inducing CD4 (+)CD25 ( low/int) effector T-Cell apoptosis and increasingregulatory T cell number [ J ] . PLoS One,2012,7 ( 10 ):e48379.
  • 6BARJON C,NIKI T,VERILLAUD B,et al. A novel mono-clonal antibody for detection of galectin-9 in tissue sec-tions :application to human tissues infected by oncogenicviruses[ J]. Infect Agent Cancer,2012,7( 1 ) :16.
  • 7JAYARAMAN P,SADA-OVALLE I,BELADI S,et al.Tim3 binding to galectin-9 stimulates antimicrobial immu-nity [J].J Exp Med,2010,207( 11) :2343-2354.
  • 8TANG 7」H, LIANG S,POTTER J,et al. Tim-3/galectin-9regulate the homeostasis of hepatic NKT cells in a murinemodel of nonalcoholic Fatty liver disease[ J]. J Immunol,2013,190(4) :1788-1796.
  • 9SHI F, GUO X,JIANG X, et al. Dysregulated Tim-3 ex-pression and its correlation with imbalanced CD4 helper Tcell function in ulcerative colitis [ J ] . Clin Immunol,2012,145(3) :230-240.
  • 10LI Y,FENG J,GENG S,et al. The N- and C-terminal car-bohydrate recognition domains of galectin-9 contribute dif-ferently to its multiple functions in innate immunity and a-daptive immunity f J ] . Mol Immunol,2011,48 ( 4 ) : 670-677.

引证文献3

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部